FDA Puts Clinical Hold on Magenta’s AML and MDS Candidate

The FDA has placed a clinical hold on Magenta Therapeutics’ Investigational New Drug (IND) application for its leukemia and myelodysplastic syndrome drug candidate, MGTA-117.
Source: Drug Industry Daily